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1. Introduction 
Cardiac muscle mainly oxidises fatty acids, ketone 
bodies and pyruvate originating from either glycolysis 
or glucogenolysis, or from lactate oxidation. The 
formation of pyruvate and its oxidation by mito- 
chondria are controlled directly by the reoxidation 
of extra-mitochondrial NADH, which cannot operate 
directly via the respiratory chain [ 1,2] . This reoxida- 
tion probably occurs via the Borst cycle [3] , which 
involves a glutamate-aspartate exchange in mito- 
chondrial membrane [4]. As the redox potential of 
mitochondrial NAD is more electronegative than that 
of the extramitochondrial phase, it has been shown 
that the glutamate-aspartate exchange isan electro- 
genie process [5] . A protein with a high affinity for 
glutamate has been isolated from pig heart mito- 
chondria [6] . 
In isolated heart mitochondria there is rapid, oxida- 
tion of glutamate catalysed by aspartate amino-trans- 
ferase (EC 2.6.1.1). The addition of pyruvate has 
been shown to reduce considerably glutamate oxida- 
tion in heart mitochondria of rat [7], guinea pig [8] 
and pig [9] . This paper presents results indicating that 
glutamate translocation i to pig heart mitochondria 
is strongly inhibited by pyruvate. 
2. Material nd methods 
pig heart mitochondria were isolated according to 
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Mitochondrial protein was determined by the 
biuret method [ 1 I] . 
For the determination of the kinetics of glutamate 
incorporation, mitochondrla (2-3 mg protein/ml) 
were suspended ina medium containing 0.2 M sucrose, 
0.02 M MES-Tris pH 6.5 and [U-14C]sucrose by
which the extramatrix space can be determined. 
L-[3H]G1utamate was added and mitochondria 
were separated from the incubation medium after a 
given time by rapid centrifugation i  an Eppendorf 
3200 microcentrifuge. 
The supernatant was discarded and the pellet 
quickly rinsed with 0.2 M sucrose and disssolved in
0.2 ml formic acid. The radioactivity of the formic 
acid extracts was measured inan Intertechnique SL 40 
scintillation counter in the POPOP/PPO system. 
The amount of glutamate taken up by the mito- 
chondria was calculated by correcting the total [3H]- 
glutamate in the mitochondrial pellet for the gluta- 
mate contained in the extramatrix space (3.5-4 fi/mg 
protein according to the experimental conditions). 
L[G-3H]Glutamate and [U-14C]sucrose were 
obtained from the Radiochemical Centre, Amersham, 
Bucks. 
3. Results and discussion 
3.1. Kinetic parameters of glu tamate influx 
Glutamate penetration measured instate 3 follows a 
saturation curve shown in fig. 1. The Km is 0.3-0.4 mM 
(20°C, pH 6.5) and V,, 6 nmol glutamate/min/mg 
protein. Between different mitochondrial preparations 
the state 3 V,, varies from 4.9-9.5 nmol/min/mg 
protein (for 16 expt. V,, 6.6 + 0.5 nmol/min/mg 
protein). Comparable variation was observed in rat 
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Fig.1. Concentration dependance of glutamate uptake. Mitochondria (2.5 mg protein) were added to 0.95 ml medium containing 
200 mM sucrose, 20 mM MES-Tris, [U-‘*C]sucrose, glutamate concentration was varied from 0.1-10 mM. State 3 was obtained 
by addition of 0.1 mM ADP and 2.5 mM Pi. pH 6.5, 2O’C and incubation time 1 min. 
liver mitochondria with V,, values of 23 nmol [ 121 
and 9.1 nmol/min/mg protein [ 131 being measured 
under very similar conditions. Affinity appears to be 
reduced when the measurements are made in state 4, 
and saturation no longer occurs. The rates of gluta- 
mate penetration measured in the presence of rote- 
none are similar to those measured in state 4 (results 
not given here). Pi, 2.5 mM, added in state 4 increases 
glutamate uptake and this effect continues in the 
presence of mersalyl, which inhibits Pi transport 
(results not given here). Pi was observed to increase 
aspartate efflux from rat heart mitochondria [ 141. 
3.2. Inhibition by pyruvate of glutamate influx 
Figure 2 shows that pyruvate is a powerful inhibi- 
tor of glutamate entry. 
Plots of l/Vagainst pyruvate concentration, at 
different glutamate concentrations, are biphasic (fig.3). 
For 0. l-l mM pyruvate inhibition is competitive and 
the Ki is 0.6-0.7 mM. Below 0.1 mM the affinity of 
pyruvate for the transport system is increased. These 
results suggest hat there is a physiological regulation 
mechanism between pyruvate concentration and inhi- 
bition of glutamate translocation linked to the reoxi- 
dation of extramitochondrial NADH. 
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Fig.2. Time course of L-[3H]glutamate penetration in state 4 
and inhibition by pyruvate. Same conditions as in fig. 1, 
except 1 mM glutamate. Pyruvate, 2 mM, was added 10 s 
before glutamate. 
Figure 4 shows that pyruvate is not the only 
inhibitor of glutamate uptake, cu-ketoglutarate or 
oxaloacetate are also effective, although less so than 
pyruvate, and structural analogues such as ru-keto- 
butyrate or phenylpyruvate also inhibit. In contrast, 
malate has no inhibiting effect. One may note that all 
the inhibitory molecules obtain the -CO-COOH 
group. 
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Fii.3. Effect of pyruvate concentration on L-[‘HIglutamate 
uptake, determination of Ki for pyruvate in state 4. Same 
conditions as in fig. 1. Pyruvate concentration was varied from 
O-l mM. 
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Fig.4. Inhibition of glutamate uptake by pyruvate and ana- 
logues in state 3. 1 mM glutamate; 5 mM pyruvate (Pyr), 
orketoglutarate (orKG), or-ketobutyrate (orKB), phenylpyruvate 
&Pyr), oxaloacetate (OAA), or malate were added 10 s before 
glutamate. 
As a first hypothesis, one can suggest that pyruvate 
and its structural analogues act on the transport 
system which controls glutamate ntry into mito- 
chondria. A second hypothesis is that the effect of 
substrates with the -CO-COOH group (pyruvate, 
cu-ketoglutarate nd oxaloacetate) could be due to 
their intramitochondrial metabolism (fig.5). The 
inhibitory effect of a-ketoglutarate could result from 
a reduction in aspartate amino-transferase activity 
following uptake of this substrate. In contrast, oxalo- 
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Fig.5. Translocation of glutamate and pyruvate in pig heart 
mitochondria. (A) Electrogenic exchange glutamateaspartate 
according to [5]. (B) Pyruvate carrier-pyruvate dehydrog- 
enase complex. (C) Cytosolic face. (M) Matrix face. 
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acetate, which can diffuse easily in heart mitochondria 
[15,16], should stimulate glutamate ntry, whereas, 
as the result in fig.4 shows, it causes inhibition. 
Malate, which can give rise to oxaloacetate in mito- 
chondria has no inhibitory effect on glutamate trans- 
location, suggesting that intramitochondrial oxalo- 
acetate does not inhibit glutamate translocation while 
exogenous oxaloacetate does (fig.5). 
3.3. Effects of rotenone, arsenite and Cap on 
glutamate influx, in the absence and presence of 
pyruvate 
Following the second hypothesis, the inhibition of 
glutamate entry by pyrnvate could be explained by 
competition for oxaloacetate between aspartate amino 
transferase (EC 2.6.1.1) and citrate synthase (EC 
4.1.3.7.) (fig.5). In these conditions inhibition or 
activation of pyruvate dehydrogenase would affect 
glutamate translocation. 
Figure 6 (exp. a) shows that rotenone reduces by 
about 15% glutamate translocation measured instate 3. 
Addition of rotenone slightly reduces the inhibition 
6 
t ~ Controi - 
of glutamate translocation by pyruvate (1 nmol gluta- 
mate/mg protein/min in the presence of pyruvate t
rotenone instead of 0.2 nmol in the presence of pyru- 
vate alone). Rotenone, which inhibits oxidative 
decarboxylation of pyruvate thus has little effect on 
glutamate translocation i the presence of pyruvate. 
Sodium arsenite, apowerful inhibitor of pyruvate 
dehydrogenase, markedly reduces inhibition of gluta- 
mate translocation (fig.6, exp. b). 
The addition of 0.2 mM Ca” (tig.6, exp. c) has 
little effect on glutamate translocation. In contrast, 
Cap, an activator of phosphatase linked to the action 
of pyruvate dehydrogenase, ignificantly reinforces 
the inhibitory effect of pyruvate. 
3.4. Effects of palmityl CoA oxidation and amino- 
oxyacetate on glutamate influx 
The results in fig.7 show that palmityl CoA oxida- 
tion (a generator of intramitochondrial cetyl CoA) 
does not affect influx, while amino-oxyacetate, an
aspartate amino-transferase inhibitor [ 181, reduces 
glutamate translocation by only 30%. 
Cant rol 
a b C 
Fig.6. Effect of rotenone, sodiumarseuite and calcium on L-[‘HIglutamate uptake in presence of pyruvate in state 3. Same condi- 
tions as in fg.1 for the three experiments. (a) Effect of rotenone (Rot) (15 Mgg/mg protein). (b) Effect of 1 mM sodium-arsenite 
(Ars). (c) Effect of 0.2 mM calcium. F’yruvate, 5 mM, was added 10 s before glutamate and rotenone, sodium arsenite or calcium 
2 min before pyruvate. 
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Fig.7. Effect of palmityl CoA oxidation and aspartate amino- 
transferase inhibition by amino-oxyacetate on L-[ ‘H]gluta- 
mate uptake. Same’conditions as in fig.1 except: state 3 was 
obtained by addition of 2 mM ADP and 2.5 mM Pi. Pyruvate, 
5 mM, was added 10 s before glutamate. Car&me, 5 mM, 
+ palmityl CoA, 5 MM, or 10 mM amino-oxyacetate (AOA) 
were added 2 min before glutamate. 
4. conclusions 
The inhibition of glutamate oxidation in heart 
mitochondria by pyruvate follows inhibition of 
glutamate transport by this substrate. Several hypo- 
theses could explain this inhibition: 
1. 
2. 
Pyruvate is a competitive inhibitor which acts 
directly on the glutamate binding site of the tran- 
sport system. All structural analogues studied 
containing the -CO-COOH group are inhibitors. 
Inhibition of glutamate translocation follows com- 
petition for intramitochondrial oxaloacetate. Only 
the results obtained in the presence of Na arsenite 
support his hypothesis. 
3. One of us (Stepien, G., unpublished) has shown 
that pyruvate translocation i  pig heart mitochon- 
dria is controlled by the transmembrane A pH. It is 
possible that in the membrane there is competition 
for energy between glutamate transport and pyru- 
vate transport. 
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